Cancer Causes & Control

, Volume 23, Issue 12, pp 1929–1937

Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area

  • Zhihong Gong
  • Elizabeth A. Holly
  • Paige M. Bracci
Original Paper



Obesity has been consistently associated with increased risk of pancreatic cancer incidence and mortality. However, studies of obesity and overall survival in patients with pancreatic cancer are notably lacking, especially in population-based studies.


Active and passive follow-up were used to determine vital status and survival for 510 pancreatic cancer patients diagnosed from 1995 to 1999 in a large population-based case–control study in the San Francisco Bay Area. Survival rates were computed using Kaplan–Meier methods. Hazard ratios (HR) and 95 % confidence intervals (CI) were estimated in multivariable Cox proportional hazards models as measures of the association between pre-diagnostic obesity and pancreatic cancer survival.


An elevated hazard ratio of 1.3 (95 % CI, 0.91–1.81) was observed for obese [body mass index (BMI) ≥ 30] compared with normal range BMI (<25) patients. Associations between BMI and overall survival did not statistically significantly vary by known prognostic and risk factors (all p-interaction ≥0.18), yet elevated HRs consistently were observed for obese compared with normal BMI patients [localized disease at diagnosis (HR, 3.1), surgical resection (HR, 1.6), ever smokers (HR, 1.6), diabetics (HR, 3.3)]. Poor survival was observed among men, older patients, more recent and current smokers, whereas improved survival was observed for Asian/Pacific Islanders.


Our results in general provide limited support for an association between pre-diagnostic obesity and decreased survival in patients with pancreatic cancer. Patterns of reduced survival associated with obesity in some patient subgroups could be due to chance and require assessment in larger pooled studies.


Pancreatic cancer Obesity Survival Population-based cohort 


  1. 1.
    American Cancer Society. Cancer Facts & Figures 2011. Atlanta: American Cancer SocietyGoogle Scholar
  2. 2.
    Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300PubMedCrossRefGoogle Scholar
  3. 3.
    Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134PubMedCrossRefGoogle Scholar
  4. 4.
    Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE et al (2011) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129:1708–1717PubMedCrossRefGoogle Scholar
  5. 5.
    Jiao L, Berrington de Gonzalez A, Hartge P, Pfeiffer RM, Park Y, Freedman DM et al (2010) Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 21:1305–1314PubMedCrossRefGoogle Scholar
  6. 6.
    Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB et al (2010) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170:791–802PubMedCrossRefGoogle Scholar
  7. 7.
    Stevens RJ, Roddam AW, Spencer EA, Pirie KL, Reeves GK, Green J et al (2009) Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer 124:2400–2405PubMedCrossRefGoogle Scholar
  8. 8.
    Coughlin SS, Calle EE, Patel AV, Thun MJ (2000) Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11:915–923PubMedCrossRefGoogle Scholar
  9. 9.
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638PubMedCrossRefGoogle Scholar
  10. 10.
    Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML et al (2009) Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301:2553–2562PubMedCrossRefGoogle Scholar
  11. 11.
    Olson SH, Chou JF, Ludwig E, O’Reilly E, Allen PJ, Jarnagin WR et al (2010) Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 127:2412–2419PubMedCrossRefGoogle Scholar
  12. 12.
    McWilliams RR, Matsumoto ME, Burch PA, Kim GP, Halfdanarson TR, de Andrade M et al (2010) Obesity adversely affects survival in pancreatic cancer patients. Cancer 116:5054–5062PubMedCrossRefGoogle Scholar
  13. 13.
    Benns M, Woodall C, Scoggins C, McMasters K, Martin R (2009) The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol 16:2565–2569PubMedCrossRefGoogle Scholar
  14. 14.
    Williams TK, Rosato EL, Kennedy EP, Chojnacki KA, Andrel J, Hyslop T et al (2009) Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 208:210–217PubMedCrossRefGoogle Scholar
  15. 15.
    Noun R, Riachy E, Ghorra C, Yazbeck T, Tohme C, Abboud B et al (2008) The impact of obesity on surgical outcome after pancreaticoduodenectomy. Jop 9:468–476PubMedGoogle Scholar
  16. 16.
    House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M et al (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12:270–278PubMedCrossRefGoogle Scholar
  17. 17.
    Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H et al (2009) Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 144:216–221PubMedCrossRefGoogle Scholar
  18. 18.
    Balentine CJ, Enriquez J, Fisher W, Hodges S, Bansal V, Sansgiry S et al (2010) Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14:1832–1837PubMedCrossRefGoogle Scholar
  19. 19.
    Khan S, Sclabas G, Reid-Lombardo K, Sarr MG, Nagorney D, Kendrick ML et al (2010) Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma? J Gastrointest Surg 14:1820–1825PubMedCrossRefGoogle Scholar
  20. 20.
    Tsai S, Choti MA, Assumpcao L, Cameron JL, Gleisner AL, Herman JM et al (2010) Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg 14:1143–1150PubMedCrossRefGoogle Scholar
  21. 21.
    Gong Z, Holly EA, Bracci PM (2011) Survival in population-based pancreatic cancer patients: San Francisco Bay Area, 1995–1999. Am J Epidemiol 174:1373–1381PubMedCrossRefGoogle Scholar
  22. 22.
    Holly EA, Eberle CA, Bracci PM (2003) Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 158:432–441PubMedCrossRefGoogle Scholar
  23. 23.
    Cox DR (1972) Regression models with life-tables (with discussion). J Roy Stat Soc Ser B 34:187–220Google Scholar
  24. 24.
    Ramsey AM, Martin RC (2011) Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg 15:1633–1642PubMedCrossRefGoogle Scholar
  25. 25.
    Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928–1937PubMedCrossRefGoogle Scholar
  26. 26.
    Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT (2011) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control 22:189–197PubMedCrossRefGoogle Scholar
  27. 27.
    Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P et al (2009) Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 170:403–413PubMedCrossRefGoogle Scholar
  28. 28.
    Ansary-Moghaddam A, Huxley R, Barzi F, Lawes C, Ohkubo T, Fang X et al (2006) The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 15:2435–2440PubMedCrossRefGoogle Scholar
  29. 29.
    Wang F, Gupta S, Holly EA (2006) Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 15:1458–1463PubMedCrossRefGoogle Scholar
  30. 30.
    Bosetti C, Lucenteforte E, Silverman DT et al (2011) Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol 22:1420–1426PubMedCrossRefGoogle Scholar
  31. 31.
    Tranah GJ, Holly EA, Wang F, Bracci PM (2011) Cigarette, cigar and pipe smoking, passive smoke exposure, and risk of pancreatic cancer: a population-based study in the San Francisco Bay Area. BMC Cancer 11:138PubMedCrossRefGoogle Scholar
  32. 32.
    Godsland IF (2010) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 118:315–332CrossRefGoogle Scholar
  33. 33.
    Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473–481PubMedCrossRefGoogle Scholar
  34. 34.
    Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846PubMedCrossRefGoogle Scholar
  35. 35.
    Mossner J, Logsdon CD, Goldfine ID, Williams JA (1987) Do insulin and the insulin like growth factors (IGFs) stimulate growth of the exocrine pancreas? Gut 28(Suppl):51–55PubMedCrossRefGoogle Scholar
  36. 36.
    Margetic S, Gazzola C, Pegg GG, Hill RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26:1407–1433PubMedCrossRefGoogle Scholar
  37. 37.
    White PB, True EM, Ziegler KM, Wang SS, Swartz-Basile DA, Pitt HA et al (2010) Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J Gastrointest Surg 14:1888–1893 (discussion 1893–1894)PubMedCrossRefGoogle Scholar
  38. 38.
    Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115:86–96PubMedCrossRefGoogle Scholar
  39. 39.
    Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR et al (2004) Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13:779–786PubMedGoogle Scholar
  40. 40.
    Ramos EJ, Xu Y, Romanova I et al (2003) Is obesity an inflammatory disease? Surgery 134:329–335PubMedCrossRefGoogle Scholar
  41. 41.
    Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72:1605–1621PubMedCrossRefGoogle Scholar
  42. 42.
    Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R et al (2007) The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67:585–592PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Zhihong Gong
    • 1
    • 2
  • Elizabeth A. Holly
    • 1
  • Paige M. Bracci
    • 1
  1. 1.Department of Epidemiology and BiostatisticsUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Department of Cancer Prevention and ControlRoswell Park Cancer InstituteBuffaloUSA

Personalised recommendations